Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.
Giordano A, Gao H, Cohen EN, Anfossi S, Khoury J, Hess K, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Lucci A, Reuben JM. Giordano A, et al. Among authors: krishnamurthy s. Ann Oncol. 2013 Oct;24(10):2515-2521. doi: 10.1093/annonc/mdt223. Epub 2013 Jun 24. Ann Oncol. 2013. PMID: 23798614 Free PMC article.
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.
Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, Viens P, Symmans WF, Birnbaum D, Van Laere SJ. Bertucci F, et al. Among authors: krishnamurthy s. Ann Oncol. 2014 Feb;25(2):358-65. doi: 10.1093/annonc/mdt496. Epub 2013 Dec 2. Ann Oncol. 2014. PMID: 24299959 Free PMC article.
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.
Yang CH, Gonzalez-Angulo AM, Reuben JM, Booser DJ, Pusztai L, Krishnamurthy S, Esseltine D, Stec J, Broglio KR, Islam R, Hortobagyi GN, Cristofanilli M. Yang CH, et al. Among authors: krishnamurthy s. Ann Oncol. 2006 May;17(5):813-7. doi: 10.1093/annonc/mdj131. Epub 2006 Jan 10. Ann Oncol. 2006. PMID: 16403809 Free article. Clinical Trial.
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.
Cristofanilli M, Morandi P, Krishnamurthy S, Reuben JM, Lee BN, Francis D, Booser DJ, Green MC, Arun BK, Pusztai L, Lopez A, Islam R, Valero V, Hortobagyi GN. Cristofanilli M, et al. Among authors: krishnamurthy s. Ann Oncol. 2008 Oct;19(10):1713-9. doi: 10.1093/annonc/mdn352. Epub 2008 May 29. Ann Oncol. 2008. PMID: 18515258 Free PMC article. Clinical Trial.
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. Dawood S, et al. Among authors: krishnamurthy s. Ann Oncol. 2011 Mar;22(3):515-523. doi: 10.1093/annonc/mdq345. Epub 2010 Jul 5. Ann Oncol. 2011. PMID: 20603440 Free PMC article.
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system.
Andreopoulou E, Yang LY, Rangel KM, Reuben JM, Hsu L, Krishnamurthy S, Valero V, Fritsche HA, Cristofanilli M. Andreopoulou E, et al. Among authors: krishnamurthy s. Int J Cancer. 2012 Apr 1;130(7):1590-7. doi: 10.1002/ijc.26111. Epub 2011 Nov 30. Int J Cancer. 2012. PMID: 21469140 Free article. Clinical Trial.
1,350 results